Viewpoint reveals implications of corporate practice regulations in clinical care delivery settings, indicating regulatory frameworks need assessment.
This Viewpoint examines regulatory frameworks, limitations and exemptions, and policy implications of corporate practice of medicine doctrines.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: